Chicago, IL, September 20, 2013—Brainlab, a leading software technology company with a longstanding dedication to innovation in radiotherapy, is showcasing Elements* Radiotherapy Planning applications at the 55th Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 22-25, at the Georgia World Congress Center in Atlanta, Georgia. More than 11,000 attendees including oncologists, radiation therapists, oncology nurses, medical physicists and other related health care professionals are expected to attend this year’s annual scientific meeting. Attendees can experience the introductory applications in this powerful and ever-expanding radiotherapy portfolio at the Brainlab booth.
“Physicians are looking for intuitive and straightforward tools for their radiotherapy contouring and treatment planning process,” explains Stefan Vilsmeier, CEO and Founder of Brainlab. “Brainlab has identified, extracted and refined the most valuable, clinician-preferred features from our software and developed efficient and effective, a la carte software modules. Elements are offered through flexible business models that range from simple, single licenses up to multiple offerings across multiple departments. We want to provide Elements in such a way that facilities can access them in the way they want and expect to use them. These applications are true change agents and provide a new kind of streamlined planning while fostering collaboration across disciplines.”
Brainlab Elements provide immediate access to a suite of radiotherapy planning solutions that work seamlessly together, delivering capability without complexity. This modular approach allows users to define the Elements they need and have the flexibility to distribute dynamically across various workstations. Brainlab Elements bridge disciplines and offer working and scalable connections between clinical subspecialties like radiation oncology and neurosurgery.
Common to all Elements applications are an intuitive user environment and indication-specific workflows that are designed to facilitate best practice. Streamlined and largely automated, Elements increase efficiency while enhancing decision making for radiation oncologists. Clinicians can launch, manipulate and control Elements via touch or mouse.
“ASTRO offers the ideal setting for clinicians to experience, first hand, our introductory Brainlab Elements Radiotherapy Planning applications,” said Stefan Seifert, Director of Product Line Marketing at Brainlab. “This is only the beginning in terms of our planned Elements portfolio. We will be demonstrating planning applications including Atlas Segmentation, Image Fusion, SmartBrush® and AVM outlining in addition to dedicated, indication-specific dose planning prototypes.”
Visit Brainlab at booth #1243 and experience how Elements can adapt to your needs.
Brainlab develops, manufactures and markets software-driven medical technology, enabling access to improved, more efficient, less-invasive patient treatments. Core products revolve around less-invasive image guided surgery technology, more accurate and effective radiation therapy, and integration through planning and collaboration systems that bring patient data and physicians together.
Brainlab technology currently powers treatments in the fields of neurosurgery, radiation oncology, orthopedics, ENT, CMF, spine, and trauma. Privately held since its formation in Munich, Germany in 1989, Brainlab has more than 5,000 systems installed in about 80 countries. Brainlab employs 1,120 people in 17 offices worldwide, including 290 Research & Development engineers, who form a crucial part of the product development team.
ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals that specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, the Society is dedicated to improving patient care through professional education and training, support for clinical practice and health policy standards, advancement of science and research, and advocacy.
ASTRO publishes two medical journals, International Journal of Radiation Oncology•Biology•Physics (www.redjournal.org) and Practical Radiation Oncology (www.practicalradonc.org); developed and maintains an extensive patient website, www.rtanswers.org; and created the Radiation Oncology Institute (www.roinstitute.org), a non-profit foundation to support research and education efforts around the world that enhance and confirm the critical role of radiation therapy in improving cancer treatment. To learn more about ASTRO, visit www.astro.org.
*Work in progress